Vimarsana
Biggest News Aggregation in the World

Hypersensitivity Reactions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hypersensitivity Reactions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hypersensitivity Reactions Today - Breaking & Trending Today

BioLineRx : Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024 - Vimarsana News

BioLineRx : Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER ...

Legend Biotech's CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma -April 05, 2024 at 11:31 pm EDT - Vimarsana News

Legend Biotech's CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma -April 05, 2024 at 11:31 pm EDT

New indication for this one-time infusion may provide patients with a treatment-free respite as early as first relapse ...

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference - Vimarsana News

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

Chiesi Global Rare Diseases Presents Long-Term Data on Treatment with Velmanase Alfa in Alpha-Mannosidosis and Announces Additional Presentations at the 20th Annual WORLDSymposium™ Research Meeting - Vimarsana News

Chiesi Global Rare Diseases Presents Long-Term Data on Treatment with Velmanase Alfa in Alpha-Mannosidosis and Announces Additional Presentations at the 20th Annual WORLDSymposium™ Research Meeting

/PRNewswire/ -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living...

Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference - Vimarsana News

Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference

—ARIKAYCE® (amikacin liposome inhalation suspension) Delivers Full-Year 2023 Revenues Exceeding the Upper End of Guidance Range with Unaudited Global Net...